Par Pharma Can't Get 2nd Fed. Circ. Win Over AIDS Drug
Par Pharmaceutical Inc. couldn't persuade the Federal Circuit to overturn for the second time a district court's finding that its patent for an appetite stimulant drug for AIDS patients was invalid,...To view the full article, register now.
Already a subscriber? Click here to view full article